UCP4 levels are significantly reduced in AD brain tissue and the UCP4 variant rs9472817 increases AD risk, especially in APOE4 carriers, suggesting a connection between UCP4 and APOE4 in disease progression (de la Monte and Wands, 2006; Montesanto et al., 2016). The gene discussed is APOE; the disease is Alzheimer disease.